Pharmacology
- The Future Of Leukemia Treatment: No Chemotherapy And No Side-Effects
-
Patients with terminal forms of leukemia and lymphoma who have run out of treatment options could still aid science- a Phase 1 trial into a new class of BTK (Bruton's Tyrosine Kinase) inhibiting drugs at Derriford Hospital in Plymouth. If it works, ...
Article - News Staff - Mar 19 2014 - 1:10pm
- FDA Says Male Enhancement Supplements Contained Undisclosed Drugs
-
The Food and Drug Administration announced Thursday that a Pennsylvania-based company is voluntarily recalling several products marketed as dietary supplements for “male enhancement” after the agency says it found they contained active drugs. Nova Product ...
Blog Post - Brandon T. Bisceglia - Apr 2 2014 - 10:31pm
- How To Get Men To Take Them- Note That Statins Can Lead To More Sex
-
Erectile dysfunction is common among older men with cardiovascular risk factors where cholesterol-lowering statins are frequently prescribed. Matching curves have suggested a negative association between statin therapy and testosterone levels, leading to ...
Article - News Staff - Mar 29 2014 - 10:00am
- Anxiety Drugs, Sleeping Pills Linked To Risk Of Death
-
Anti-anxiety drugs and sleeping pills have been linked to an increased risk of death, according to a large study published in BMJ which shows that several anxiolytic (anti-anxiety) drugs or hypnotic drugs (sleeping pills) are associated with a doubling in ...
Article - News Staff - Apr 7 2014 - 4:34am
- Cognition Therapeutics Receives Patent For Alzheimer's Disease Drug
-
Alzheimer’s disease is a debilitating neurodegenerative disease and the most common form of dementia. Symptoms include irritability, confusion, mood swings, language difficulties and memory loss. Cognitive dysfunction becomes more pronounced as the disease ...
Article - News Staff - Apr 2 2014 - 6:00am
- GRC 27864 For Chronic Inflammatory Disease Enters Human Clinical Trials
-
Glenmark Pharmaceuticals has announced that GRC 27864 is entering human trials. GRC 27864 targets Microsomal Prostaglandin E synthase-1 (mPGES-1) as a therapeutic target in pain management. Selective mPGES-1 inhibitors are expected to inhibit increased p ...
Article - News Staff - Apr 5 2014 - 8:35pm
- The Risks Of Acetaminophen Toxicity From Over The Counter And Prescription Pain Medications
-
The dose makes the poison, it is often said. And that can be the case even with beneficial products like Acetaminophen. Acetaminophen is a commonly used pain reliever that is available in over-the-counter products (Tylenol®) and prescription medications, w ...
Article - News Staff - Apr 6 2014 - 11:10pm
- Off-Label Antipsychotic Drug Use For Foster Care Youth Is Increasing
-
Antipsychotic medications are often used for in 'second-generation' form- that is, for unlabeled indications, such as treatment of children and adolescents with attention-deficit hyperactivity disorder (ADHD). Currently, atypical antipsychotic m ...
Article - News Staff - Apr 7 2014 - 12:13pm
- Liver Let Die: Gambling With Supplements
-
According to the FDA, a drug is a substance (other than nutrients) intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or function of the body. Seems clear enough-- that is, until politics an ...
Article - Josh Bloom - Apr 8 2014 - 8:56am
- 8 More Years Of Life From Glucosamine? Puhhleaze
-
It’s been all over the news. Depending on the accuracy of the headline, you may conclude that worms live longer when exposed to glucosamine, mice live 10 percent longer when fed glucosamine or that YOU will live 8 years longer if you take the stuff. As u ...
Article - Josh Bloom - Apr 15 2014 - 5:19pm

